19 drug(s) with this reaction
16,313 total reports
Product Use Issue has been reported as an adverse reaction across 19 drug(s) manufactured by Haleon Us Holdings Llc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 16,313 adverse event reports mention product use issue in connection with Haleon Us Holdings Llc products.
This page provides a breakdown of which Haleon Us Holdings Llc drugs are most commonly associated with product use issue, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Haleon Us Holdings Llc drugs have product use issue listed in their FDA adverse event reports, sorted by report count:
In addition to product use issue, the following adverse reactions have been reported across Haleon Us Holdings Llc's drug portfolio:
19 drug(s) manufactured by Haleon Us Holdings Llc have product use issue listed in their FDA adverse event reports: DICLOFENAC SODIUM, CALCIUM CARBONATE, FLUTICASONE PROPIONATE, IBUPROFEN SODIUM, IBUPROFEN TABLETS, COATED, and others.
There are a combined 16,313 reports of product use issue across 19 Haleon Us Holdings Llc drug(s) in the FDA adverse event database.